Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Circulation

• Publication date

  2008-10-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.108.769984PMID 18809798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

  2011cited by this paper
• Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure

  2008cited by this paper
• Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

  2008cited by this paper
• MicroRNAs: novel regulators in cardiac development and disease.

  2008cited by this paper
• Widespread changes in protein synthesis induced by microRNAs

  2008cited by this paper
• Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus

  2008cited by this paper
• Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA

  2007cited by this paper
• MicroRNA-133 controls cardiac hypertrophy

  2007cited by this paper
• Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

  2007cited by this paper
• MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

  2007cited by this paper
• MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure

  2007cited by this paper
• Critical roles for Dicer in the female germline.

  2007cited by this paper
• Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.

  2007cited by this paper
• MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy

  2007cited by this paper
• MicroRNA Expression Is Required for Pancreatic Islet Cell Genesis in the Mouse

  2007cited by this paper
• Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis

  2007cited by this paper
• Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple small-RNA-mediated pathways.

  2006cited by this paper
• A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

  2006cited by this paper
• The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

  2006cited by this paper
• MEF2 Activates a Genetic Program Promoting Chamber Dilation and Contractile Dysfunction in Calcineurin-Induced Heart Failure

  2006cited by this paper
• MicroRNAs Regulate Brain Morphogenesis in Zebrafish

  2005cited by this paper
• The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution

  2005cited by this paper
• The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb.

  2005cited by this paper
• Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

  2005cited by this paper
• Identification of hundreds of conserved and nonconserved human microRNAs

  2005cited by this paper
• MicroRNA biogenesis: coordinated cropping and dicing

  2005cited by this paper
• MicroRNAs: a developing story.

  2005cited by this paper
• Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth.

  2005cited by this paper
• Phylogenetic shadowing and computational identification of human microRNA genes.

  2005cited by this paper
• Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Dicer Is Required for Embryonic Angiogenesis during Mouse Development*

  2005cited by this paper
• The Microprocessor complex mediates the genesis of microRNAs

  2004cited by this paper
• MCIP1 Overexpression Suppresses Left Ventricular Remodeling and Sustains Cardiac Function After Myocardial Infarction

  2004cited by this paper
• Transcription and processing of human microRNA precursors.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

  2003cited by this paper
• Dicer is essential for mouse development

  2003cited by this paper
• The nuclear RNase III Drosha initiates microRNA processing

  2003cited by this paper
• Dicer is essential for mouse development

  2003cited by this paper
• Jcb: Article Introduction

  2002cited by this paper
• Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein

  2001cited by this paper
• Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart

  2000cited by this paper
• Variation in the reversibility of evolution

  2000cited by this paper
• HIF‐1α is required for solid tumor formation and embryonic vascularization

  1998cited by this paper
• HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

  1998cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• Developmental regulation of myosin gene expression in mouse cardiac muscle

  1990cited by this paper
• Materials and Methods Figs. S1 to S4 Tables S1 to S5 References and Notes Micrornas Regulate Brain Morphogenesis in Zebrafish

  year unknowncited by this paper

• Profiling of the microRNA transcriptome in feline whole blood

  2025cites this paper
• The Hidden Regulators: MicroRNAs in Pediatric Heart Development and Disease

  2025cites this paper
• Role and relevance of exosome-mediated epigenetic regulation in the pathogenesis, diagnosis and treatment of cardiovascular diseases (Review)

  2025cites this paper
• Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders

  2025cites this paper
• Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration—A Comprehensive Review

  2025cites this paper
• Rare DCM associated variants in pre-miR-208a disrupt miRNA maturation and function

  2025cites this paper
• Heracles and the Lernaean Hydra: uncovering new layers of transcriptome regulation.

  2024cites this paper
• Cardiac Fibroblast Activation Induced by Oxygen–Glucose Deprivation Depends on the HIF-1α/miR-212-5p/KLF4 Pathway

  2023cites this paper
• Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets

  2023cites this paper
• Inflammatory microRNAs in cardiovascular pathology: another brick in the wall

  2023cites this paper
• Integrated small RNA, mRNA and protein omics reveal a miRNA network orchestrating metabolic maturation of the developing human heart

  2023cites this paper
• Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target

  2023cites this paper
• Interoception, heart failure and exosomal cargo as potential biomarkers

  2023cites this paper
• 4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification.

  2023cites this paper
• MicroRNA-216a is essential for cardiac angiogenesis

  2023cites this paper
• Non-Coding RNA-Mediated Gene Regulation in Cardiovascular Disorders: Current Insights and Future Directions

  2023cites this paper
• Post-translational modifications upon mitochondrial dysfunction in heart failure.

  2023cites this paper
• Circulating microRNAs as potential novel biomarkers in cardiovascular diseases: Emerging role, biogenesis, current knowledge, therapeutics and the road ahead

  2022cites this paper
• MicroRNAs in Dystrophinopathy

  2022cites this paper
• Defining the molecular underpinnings controlling cardiomyocyte proliferation.

  2022cites this paper
• Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy

  2022cites this paper
• MicroRNAs in Mechanical Homeostasis.

  2022cites this paper
• Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease

  2022cites this paper
• The Overexpression of miR-377 Aggravates Sepsis-Induced Myocardial Hypertrophy by Binding to Rcan2 and Mediating CaN Activity

  2022cites this paper
• miR-208a Promotes Apoptosis in H9c2 Cardiomyocytes by Targeting GATA4

  2021cites this paper
• MiR-590-5p inhibits pathological hypertrophy mediated heart failure by targeting RTN4

  2021cites this paper
• Aerobic exercise modulates noncoding RNA network upstream of FNDC5 in the Gastrocnemius muscle of high-fat-diet-induced obese mice

  2021cites this paper
• The role of miR‐29 family in disease

  2021cites this paper
• miRNA in cardiac development and regeneration

  2021cites this paper
• Identification of Nrf2-responsive microRNA networks as putative mediators of myocardial reductive stress

  2021cites this paper
• The emerging role of miRNA-132/212 cluster in neurologic and cardiovascular diseases: Neuroprotective role in cells with prolonged longevity.

  2021cites this paper
• The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint

  2021cites this paper
• Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model

  2021cites this paper
• MicroRNAs and Calcium Signaling in Heart Disease

  2021cites this paper
• miR-29a activates expression of α-cardiac myosin heavy chain via β1 thyroid hormone receptor in neonatal rats

  2020cites this paper
• Insights into role of microRNAs in cardiac development, cardiac diseases, and developing novel therapies

  2020cites this paper
• The non-coding side of cardiac differentiation and regeneration.

  2020cites this paper
• Are microRNAs responsible for cardiac hypertrophy in fish and mammals? What we can learn in the activation process in a zebrafish ex vivo model.

  2020cites this paper
• Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies

  2020cites this paper
• Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era

  2020cites this paper
• An Overview of Non-coding RNAs and Cardiovascular System.

  2020cites this paper
• MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy

  2019cites this paper
• RNAase III-Type Enzyme Dicer Regulates Mitochondrial Fatty Acid Oxidative Metabolism in Cardiac Mesenchymal Stem Cells

  2019cites this paper
• miR-221 and -222 target CACNA1C and KCNJ5 leading to altered cardiac ion channel expression and current density

  2019cites this paper
• microRNAs in Nutritional Signaling and Metabolic Syndrome

  2019cites this paper
• microRNA‐25 promotes cardiomyocytes proliferation and migration via targeting Bim

  2019cites this paper
• MiR-1/133 attenuates cardiomyocyte apoptosis and electrical remodeling in mice with viral myocarditis.

  2019cites this paper
• Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium

  2019cites this paper
• Long-term impact of maternal high-fat diet on offspring cardiac health: role of micro-RNA biogenesis

  2019cites this paper
• The role of cardiac transcription factor NKX2-5 in regulating the human cardiac miRNAome

  2019cites this paper
• Alteration in microRNA‐25 expression regulate cardiac function via renin secretion

  2018cites this paper
• Rescuing infusion of miRNA-1 prevents cardiac remodeling in a heart-selective miRNA deficient mouse.

  2018cites this paper
• Attenuation of MicroRNA-495 Derepressed PTEN to Effectively Protect Rat Cardiomyocytes from Hypertrophy

  2018cites this paper
• Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction

  2018cites this paper
• Non-coding RNAs and exercise: pathophysiological role and clinical application in the cardiovascular system.

  2018cites this paper
• Combined Use of Circulating miR-133a and NT-proBNP Improves Heart Failure Diagnostic Accuracy in Elderly Patients

  2018cites this paper
• 24 – Feedback Mechanisms for Cardiac-Specific MicroRNAs and cAMP Signaling in Electrical Remodeling

  2018cites this paper
• Exercise training prevents obesity-associated disorders: Role of miRNA-208a and MED13.

  2018cites this paper
• 2 MicroRNAs as Possible Molecular Pacemakers

  2018cites this paper
• When Knowing "Enough" May Still Not Be Enough.

  2018cites this paper
• LncRNA myocardial infarction‐associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR‐93

  2018cites this paper
• Noncoding RNAs in disease

  2018cites this paper
• Review - MicroRNAs: A new paradigm towards mechanistic insight of diseases.

  2018cites this paper
• At the heart of programming: the role of micro-RNAs

  2018cites this paper
• Circulating miR-192 is a prognostic marker in patients with ischemic cardiomyopathy.

  2018cites this paper
• Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy

  2018cites this paper
• Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

  2018cites this paper
• MicroRNA-204 Is Necessary for Aldosterone-Stimulated T-Type Calcium Channel Expression in Cardiomyocytes

  2018cites this paper
• Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease

  2018cites this paper
• Exercise Training Restores the Cardiac Microrna-16 Levels Preventing Microvascular Rarefaction in Obese Zucker Rats

  2018cites this paper
• Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study

  2018cites this paper
• The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214

  2017cites this paper
• Exercise for Cardiovascular Disease Prevention and Treatment

  2017cites this paper
• MicroRNAs in injury and repair

  2017cites this paper
• Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.

  2017cites this paper
• miR-33 Regulation of Adaptive Fibrotic Response in Cardiac Remodeling.

  2017cites this paper
• Adverse Intrauterine Environment and Cardiac miRNA Expression

  2017cites this paper
• microRNAs-Mediated MMPs Regulation: Novel Mechanism for Cardiovascular Diseases

  2017cites this paper
• MicroRNA and Its Role in Cardiovascular Disease

  2017cites this paper
• Serum MicroRNA-27b as a Screening Biomarker for Left Ventricular Hypertrophy.

  2017cites this paper
• Down-regulation of miR-15a/b accelerates fibrotic remodelling in the Type 2 diabetic human and mouse heart.

  2017cites this paper
• The Clinical Potential of Heart Failure–Related miRNAs

  2017cites this paper
• MicroRNAs in a hypertrophic heart: from foetal life to adulthood

  2017influential citation
• Non-coding RNAs in the Vasculature

  2017cites this paper
• Circulating microRNAs in heart failure

  2017cites this paper
• The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.

  2017cites this paper
• MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol

  2017cites this paper
• Noncoding RNAs in Ischemic Cardiovascular Disease and Repair Mechanisms

  2017cites this paper
• MicroRNAs as Important Regulators of Exercise Adaptation.

  2017cites this paper
• Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction).

  2016cites this paper
• microRNA expression profiling and functional annotation analysis of their targets modulated by oxidative stress during embryonic heart development in diabetic mice.

  2016cites this paper
• miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST

  2016cites this paper
• Targeting microRNAs in heart failure.

  2016cites this paper
• MicroRNAs in heart failure: from biomarker to target for therapy

  2016cites this paper
• Non-coding RNAs as modulators of the cardiac fibroblast phenotype.

  2016cites this paper
• Non-coding RNAs in eccentric cardiac remodeling and heart failure

  2016cites this paper
• Progress in micro RNA focused research in endocrinology

  2016cites this paper
• Acute RNA Interference for Basic Research and Therapy

  2016cites this paper
• From Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and Disease

  2016cites this paper
• Control of Cardiomyocyte Proliferation by p53/MDM2-Regulated microRNAs

  2016cites this paper